| The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma A Rosenwald, G Wright, WC Chan, JM Connors, E Campo, RI Fisher, ... New England Journal of Medicine 346 (25), 1937-1947, 2002 | 4750 | 2002 |
| CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by … M Pfreundschuh, L Trümper, A Österborg, R Pettengell, M Trneny, K Imrie, ... The lancet oncology 7 (5), 379-391, 2006 | 2511 | 2006 |
| Follicular lymphoma international prognostic index P Solal-Céligny, P Roy, P Colombat, J White, JO Armitage, R Arranz-Saez, ... Blood 104 (5), 1258-1265, 2004 | 2131 | 2004 |
| Stromal gene signatures in large-B-cell lymphomas G Lenz, G Wright, SS Dave, W Xiao, J Powell, H Zhao, W Xu, B Tan, ... New England Journal of Medicine 359 (22), 2313-2323, 2008 | 1964 | 2008 |
| Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia XS Puente, M Pinyol, V Quesada, L Conde, GR Ordóñez, N Villamor, ... Nature 475 (7354), 101-105, 2011 | 1873 | 2011 |
| ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia M Crespo, F Bosch, N Villamor, B Bellosillo, D Colomer, M Rozman, ... New England Journal of Medicine 348 (18), 1764-1775, 2003 | 1731 | 2003 |
| Adult haemophagocytic syndrome M Ramos-Casals, P Brito-Zerón, A López-Guillermo, MA Khamashta, ... The Lancet 383 (9927), 1503-1516, 2014 | 1370 | 2014 |
| Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma A Rosenwald, G Wright, K Leroy, X Yu, P Gaulard, RD Gascoyne, ... The Journal of experimental medicine 198 (6), 851-862, 2003 | 1340 | 2003 |
| Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia V Quesada, L Conde, N Villamor, GR Ordóñez, P Jares, L Bassaganyas, ... Nature genetics 44 (1), 47-52, 2012 | 1234 | 2012 |
| Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial G Salles, JF Seymour, F Offner, A López-Guillermo, D Belada, L Xerri, ... The Lancet 377 (9759), 42-51, 2011 | 1231 | 2011 |
| Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project M Federico, M Bellei, L Marcheselli, S Luminari, A Lopez-Guillermo, ... Journal of Clinical Oncology 27 (27), 4555-4562, 2009 | 848 | 2009 |
| CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the … M Pfreundschuh, E Kuhnt, L Trümper, A Österborg, M Trneny, L Shepherd, ... The lancet oncology 12 (11), 1013-1022, 2011 | 835 | 2011 |
| Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia M Kulis, S Heath, M Bibikova, AC Queirós, A Navarro, G Clot, ... Nature genetics 44 (11), 1236-1242, 2012 | 660 | 2012 |
| Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma L Colomo, A López-Guillermo, M Perales, S Rives, A Martı́nez, F Bosch, ... Blood 101 (1), 78-84, 2003 | 641 | 2003 |
| Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1 AJM Ferreri, E Campo, JF Seymour, R Willemze, F Ilariucci, A Ambrosetti, ... British journal of haematology 127 (2), 173-183, 2004 | 634 | 2004 |
| Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue E Zucca, A Conconi, E Pedrinis, S Cortelazzo, T Motta, ... Blood 101 (7), 2489-2495, 2003 | 634 | 2003 |
| High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma J Carreras, A Lopez-Guillermo, BC Fox, L Colomo, A Martinez, ... Blood 108 (9), 2957-2964, 2006 | 629 | 2006 |
| Landscape of somatic mutations and clonal evolution in mantle cell lymphoma S Beà, R Valdés-Mas, A Navarro, I Salaverria, D Martín-Garcia, P Jares, ... Proceedings of the National Academy of Sciences 110 (45), 18250-18255, 2013 | 597 | 2013 |
| Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction S Bea, A Zettl, G Wright, I Salaverria, P Jehn, V Moreno, C Burek, G Ott, ... Blood 106 (9), 3183-3190, 2005 | 533 | 2005 |
| Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma V Fernàndez, O Salamero, B Espinet, F Solé, C Royo, A Navarro, ... Cancer research 70 (4), 1408-1418, 2010 | 530 | 2010 |
Mireia CamósMD, PhD, Hospital Sant Joan de Deu/ Group Coordinator, Leukemia and other pediatric hemopathiesVerified email at hsjdbcn.org
